Method to determine prognosis after therapy for prostate cancer

Details for Australian Patent Application No. 2002243863 (hide)

Owner BAYLOR COLLEGE OF MEDICINE

Inventors Shariat, Shahrokh; Slawin, Kevin M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2002243863

PCT Pub. Number WO2002/068960

Priority 60/266,976 07.02.01 US

Filing date 7 February 2002

Wipo publication date 12 September 2002

International Classifications

G01N 033/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-A-2002243863

14 December 2006 Amendment Made

  The nature of the amendment is: Add priority details 60/295,498 01 Jun 2001 US and 60/295,692 04 Jun 2001 US 2002244715 Philip Morris Products S.A. The nature of the amendment is as shown in the statement(s) filed 06 Jul 2006

17 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002243864-Large signal noise cancellation in electronic article surveillance

2002243862-RFID READER WITH INTEGRATED DISPLAY FOR USE IN A PRODUCT TAG SYSTEM